Ignite Creation Date:
2024-05-06 @ 8:39 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02788175
Status:
COMPLETED
Last Update Posted:
2020-02-24
First Post:
2016-05-28
Brief Title:
Vedolizumab Anti-alpha4beta7 in Subjects With HIV Infection Undergoing Analytical Treatment Interruption
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-28
Start Date Type:
None
Primary Completion Date:
2019-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-28
First Submit QC Date:
May 28 2016
Study First Post Date:
2016-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-12-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-19
Last Update Post Date:
2020-02-24
Last Update Post Date Type:
ACTUAL